International Stem Cell CORP (ISCO) stock
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
International Stem Cell operating margin
Operating margin is operating income as a percentage of revenue.
International Stem Cell's operating margin for the twelve months ending Jun 30, 2026 was -4.7%. For fiscal 2025 it was -2.9%, against -0.7% the year before. The highest annual figure on record is -0.7% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2.9% | −2.2 |
| FY2024 | Dec 31, 2024 | -0.7% | +7.8 |
| FY2023 | Dec 31, 2023 | -8.5% | −6.3 |
| FY2022 | Dec 31, 2022 | -2.2% | +24.5 |
| FY2021 | Dec 31, 2021 | -26.8% | +12.8 |
| FY2020 | Dec 31, 2020 | -39.5% | +20.9 |
| FY2019 | Dec 31, 2019 | -60.5% | −29.1 |
| FY2018 | Dec 31, 2018 | -31.3% | +35.0 |
| FY2017 | Dec 31, 2017 | -66.3% | +1.4 |
| FY2016 | Dec 31, 2016 | -67.7% | −7.3 |
| FY2015 | Dec 31, 2015 | -60.4% | +63.3 |
| FY2014 | Dec 31, 2014 | -123.7% | −0.9 |
| FY2013 | Dec 31, 2013 | -122.8% | +92.2 |
| FY2012 | Dec 31, 2012 | -214.9% | +35.6 |
| FY2011 | Dec 31, 2011 | -250.6% | +416.7 |
| FY2010 | Dec 31, 2010 | -667.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1.3% | −8.1 |
| Q1 FY2026 | Mar 31, 2026 | -8.2% | +1.9 |
| Q4 FY2025 | Dec 31, 2025 | -14.5% | −16.6 |
| Q3 FY2025 | Sep 30, 2025 | 4.0% | +8.1 |
| Q2 FY2025 | Jun 30, 2025 | 6.8% | +0.4 |
| Q1 FY2025 | Mar 31, 2025 | -10.1% | −1.7 |
| Q4 FY2024 | Dec 31, 2024 | 2.1% | +24.5 |
| Q3 FY2024 | Sep 30, 2024 | -4.1% | +0.8 |
| Q2 FY2024 | Jun 30, 2024 | 6.4% | +14.2 |
| Q1 FY2024 | Mar 31, 2024 | -8.4% | −8.5 |
| Q4 FY2023 | Dec 31, 2023 | -22.4% | −25.0 |
| Q3 FY2023 | Sep 30, 2023 | -4.9% | +12.7 |
| Q2 FY2023 | Jun 30, 2023 | -7.8% | −9.4 |
| Q1 FY2023 | Mar 31, 2023 | 0.1% | −1.1 |
| Q4 FY2022 | Dec 31, 2022 | 2.5% | +24.7 |
| Q3 FY2022 | Sep 30, 2022 | -17.6% | +16.6 |
| Q2 FY2022 | Jun 30, 2022 | 1.5% | +51.2 |
| Q1 FY2022 | Mar 31, 2022 | 1.2% | +55.1 |
| Q2 FY2021 | Jun 30, 2021 | -22.1% | +23.8 |
| Q1 FY2021 | Mar 31, 2021 | -34.2% | −14.9 |
| Q4 FY2020 | Dec 31, 2020 | -49.7% | +37.9 |
| Q3 FY2020 | Sep 30, 2020 | -53.9% | −15.1 |
| Q2 FY2020 | Jun 30, 2020 | -45.9% | −5.4 |
| Q1 FY2020 | Mar 31, 2020 | -19.3% | +47.9 |
| Q4 FY2019 | Dec 31, 2019 | -87.6% | −30.9 |
| Q3 FY2019 | Sep 30, 2019 | -38.8% | −18.0 |
| Q2 FY2019 | Jun 30, 2019 | -40.5% | −28.5 |
| Q1 FY2019 | Mar 31, 2019 | -67.1% | −22.1 |
| Q4 FY2018 | Dec 31, 2018 | -56.7% | +47.8 |
| Q3 FY2018 | Sep 30, 2018 | -20.8% | +31.8 |
| Q2 FY2018 | Jun 30, 2018 | -12.1% | +44.8 |
| Q1 FY2018 | Mar 31, 2018 | -45.0% | +7.2 |
| Q4 FY2017 | Dec 31, 2017 | -104.5% | −35.0 |
| Q3 FY2017 | Sep 30, 2017 | -52.5% | +12.4 |
| Q2 FY2017 | Jun 30, 2017 | -56.9% | +8.3 |
| Q1 FY2017 | Mar 31, 2017 | -52.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -69.4% | – |
| Q3 FY2016 | Sep 30, 2016 | -65.0% | – |
| Q2 FY2016 | Jun 30, 2016 | -65.2% | – |
See a number that looks wrong?